![G. Kahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
G. Kahn
Directeur/Membre du Conseil chez
SOLID BIOSCIENCES INC.
Fortune : 21 726 $ au 31/05/2026
Profil
G.
Clare Kahn currently works at Solid Biosciences, Inc., as Independent Director from 2021, Stoke Therapeutics, Inc., as Independent Director from 2026, and Clare Kahn Pharma Consulting LLC, as President from 2016.
Dr. Kahn also formerly worked at Pfizer Inc., as Vice President-Global Innovative Pharma from 2014 to 2016, GSK Plc, as Vice President-Regulatory Affairs from 1999 to 2010, the University of Pennsylvania, as Assistant Professor from 1981 to 1985, and X-Vax Technology, Inc., as Chief Regulatory & Preclinical Development Officer from 2018 to 2019.
Dr. Kahn received her doctorate degree in 1981 from Royal Postgraduate Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 2 960 ( 0 % ) | 21 726 $ | 31/05/2026 |
Postes actifs de G. Kahn
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Membre du Conseil | 02/03/2021 |
| STOKE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/04/2026 |
Clare Kahn Pharma Consulting LLC | President | 01/06/2016 |
Anciens postes connus de G. Kahn
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/06/2016 |
| GSK PLC | Conseiller Juridique Général | 01/01/2010 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1985 |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Directeur Technique/Scientifique/R&D | - |
Formation de G. Kahn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Royal Postgraduate Medical School
 Royal Postgraduate Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clare Kahn Pharma Consulting LLC |
